Treatment of Depression in Acute Coronary Syndromes with Selective Serotonin Reuptake Inhibitors

被引：0
|
作者：
Joost P. van Melle
Peter de Jonge
Maarten P. van den Berg
Harm J. Pot
Dirk J. van Veldhuisen
机构：
[1] University Medical Center Groningen,Department of Cardiology, Thoraxcenter
[2] University of Groningen,Department of Internal Medicine and Psychiatry
[3] University Medical Center Groningen,Department of Psychiatry
[4] University of Groningen,undefined
[5] University Medical Center Groningen,undefined
[6] University of Groningen,undefined
来源：
Drugs | 2006年 / 66卷
关键词：
Acute Coronary Syndrome; Heart Rate Variability; Fluoxetine; Paroxetine; Sertraline;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Depression in patients with acute coronary syndromes (ACS) is common and associated with impaired cardiovascular prognosis in terms of cardiac mortality and new cardiovascular events. It remains unclear whether antidepressant treatment may reverse these effects. In this review, the literature is evaluated on (i) the antidepressant efficacy of selective serotonin reuptake inhibitors (SSRIs) for depression in patients with ACS; (ii) the pleiomorphic effects of SSRIs that may be associated with cardiovascular prognosis; and (iii) the effects of SSRIs on cardiovascular prognosis.
引用
收藏
页码：2095 / 2107
页数：12
相关论文
共 50 条
  • [1] Treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors
    van Melle, Joost P.
    de Jonge, Peter
    van den Berg, Maarten P.
    Pot, Harm J.
    van Veldhuisen, Dirk J.
    DRUGS, 2006, 66 (16) : 2095 - 2107
  • [2] DEPRESSION AND SELECTIVE SEROTONIN REUPTAKE INHIBITORS
    WESTWICK, F
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1990, 44 (05): : 367 - 367
  • [3] Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes
    Ziegelstein, Roy C.
    Meuchel, Jennifer
    Kim, Thomas J.
    Latif, Madiha
    Alvarez, William
    Dasgupta, Neela
    Thombs, Brett D.
    AMERICAN JOURNAL OF MEDICINE, 2007, 120 (06): : 525 - 530
  • [4] Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors
    Whyte, EM
    Basinski, J
    Farhi, P
    Dew, A
    Begley, A
    Mulsant, BH
    Reynolds, CF
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (12) : 1634 - 1641
  • [5] Selective serotonin reuptake inhibitors in the treatment of child and adolescent depression
    Condat, A
    Mouren-Simeoni, MC
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2000, 26 (03): : 53 - 60
  • [6] The selective serotonin reuptake inhibitors controversy in the treatment of depression in children
    Weller E.B.
    Tucker S.
    Weller R.A.
    Current Psychiatry Reports, 2005, 7 (2) : 87 - 90
  • [7] Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression
    Mourilhe, P
    Stokes, PE
    DRUG SAFETY, 1998, 18 (01) : 57 - 82
  • [8] Risks and Benefits of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression
    Patricia Mourilhe
    Peter E. Stokes
    Drug Safety, 1998, 18 : 57 - 82
  • [9] Depression Treatment With Selective Serotonin Reuptake Inhibitors for the Postacute Coronary Syndrome Population: A Literature Review
    Regan, Karen L.
    JOURNAL OF CARDIOVASCULAR NURSING, 2008, 23 (06) : 489 - 496
  • [10] Selective serotonin reuptake inhibitors and delusional depression
    Rothschild, AJ
    Phillips, KA
    AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (06): : 977 - 978
12345